Nigeria

Nigeria is the fifth country to detect the virus since the Democratic Republic of the Congo (DRC) declared an outbreak on 15 May 2026.

Without effective intervention, more than 39 million deaths could be directly attributable to AMR globally between 2025 and 2050.

Women’s health has historically received insufficient research funding and attention, while medical studies have often relied predominantly on male participants.

The Ogun State facility is wholly Nigerian-owned and produces dual active ingredient long-lasting insecticidal nets combining a pyrethroid with chlorfenapyr.

The project will cover Cameroon, Chad, Mali, Niger and Nigeria, combining water, sanitation and hygiene (WASH) interventions with disease surveillance and medical support.

Currently, about five in 10 women diagnosed with breast cancer in Africa survive for at least five years after diagnosis.

NAFDAC selected the 600 pharmacists from all 36 states and the Federal Capital Territory (FCT).

The facility is expected to produce 10 million nets annually at full capacity and create more than 600 jobs.

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, issued the directive as the government intensifies efforts to protect children from vaccine-preventable diseases and strengthen the country’s capacity to respond to outbreaks.